Cardiac care and medications are constantly advancing with the latest devices and drugs.  Medicor physicians are actively participating in ongoing clinical trials to provide the latest cutting-edge therapies for their patients.  Specialized research nurses monitor every aspect of the clinical trials from start to finish.

Medicor physicians may discuss applicable trials with you for possible enrollment as part of  comprehensive cardiovascular care plan.

Representation of Medicor research experience:

Trial to Evaluate the Effect of Ticagrelor twice a day on patients with Type II Diabetes and Cardiovascular Disease but without history of heart attack and stroke.  THEMIS (enrolling June 2014).

Study to Evaluate the Effect of Long-Term Treatment with BELVIQ (FDA approved drug) on obese patients with Cardiovascular Disease or Multiple Cardiovascular risk factors as well as Type II Diabetes CAMELLIA (enrolling Mid June 2014).

Confirm the safety and reliability of the BIOTRONIK Siello S lead used with the BIOTRONIK Evia Pacemaker. Pacemaker Lead Study SIELLO (enrolling now).

Study Comparing ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease EUCLID (currently closed to enrollment).

Odyssey Outcomes is a clinical research study for individuals with Coronary heart disease who have been hospitalized within one year for a heart attack or unstable angina.  Twice monthly injection of Alliracumab to help decrease LDL (bad cholesterol) and increase HDL (good cholesterol) ODYSSEY (enrolling now).

Trial for the Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein (CETP) Inhibiation with Evacetrapib in patients at a High Risk for Vascular Outcomes.  ACCELERATE (currently closed to enrollment).

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification REVEAL (currently closed to enrollment).                                           

Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic (ASA) Therapy in Patients with History of Myocardial Infarction. PEGASUS (currently closed to enrollment).

Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery BRIDGE (enrolling now).

Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation GLORIA AF (enrolling now).

Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) risk in stable CHD patients, with documented recent Acute Coronary Syndrome (ACS) DAL-OUTCOMES (CLOSED)

A comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS). TRILOGY (CLOSED)

Multicenter, randomized, parallel group Efficacy and safety study for prevention of venous thromboembolism in hospitalized medically ill patients comparing rivaroxaban with enoxaprin. MAGELLAN (CLOSED)

Event Driven, Non-inferiority Study comparing the Efficacy and Safety of Once Daily Oral Rivaroxaban with adjusted dose oral Warfarin for the prevention of Stroke and Non Central nervous system systemic embolism in subjects with Non-Valvular Atrial fibrillation ROCKET (CLOSED)

Harmonizing Outcomes with  Revascularization and Stents in Acute Myocardial Infarction- HORIZONS-AMI  (CLOSED)

Registry to Improve the use of Evidence Based Heart Failure Therapies in the Outpatient Setting- IMPROVE-HF- (CLOSED)

Primary Objective to compare the initiation of clinical action prompted by an OptiVol Threshold crossing between monthly and quarterly review of Cardiac Compass Trends with OpitVol MEDTRONIC OPTIVOL (CLOSED)